<img height="1" width="1" src="https://www.facebook.com/tr?id=1582471781774081&amp;ev=PageView &amp;noscript=1">

Search our Blog
Ludovic Bourré, PhD

Ludovic Bourré, PhD

LinkedIn

Ludovic serves as Executive Director leading the Scientific Engagement department. He has over 15 years of Oncology R&D experience. Prior to joining Crown Bioccience, he worked at Invectys (Paris, France) as head of the pharmacology, leading the preclinical and clinical evaluation of immuno-oncology programs. Ludovic holds a PhD in Pharmacology from Nantes University (France), and served as a postdoctoral researcher in University College London and University College Cork.

Posts by this author

Germ-Free or Antibiotic-Treated Mice? Which Model for Studying the Role of the Gut Microbiota in Preclinical Studies

4 minute read

Germ-Free or Antibiotic-Treated Mice? Which Model for Studying the Role of the Gut Microbiota in Preclinical Studies

December 16, 2020

SHP2 and SOS1 Targets: Additional Players in the KRAS Inhibitors Race?

6 minute read

SHP2 and SOS1 Targets: Additional Players in the KRAS Inhibitors Race?

November 10, 2020

Evaluating Immunotherapy Mechanism of Action with Immune Cell Lineage-Specific DTR Models

5 minute read

Evaluating Immunotherapy Mechanism of Action with Immune Cell Lineage-Specific DTR Models

October 14, 2020

Digital Pathology

7 minute read

Digital Pathology

July 23, 2020

The Role of Proteomics in Oncology Biomarker Discovery

12 minute read

The Role of Proteomics in Oncology Biomarker Discovery

April 22, 2020

How to Develop Predictive Cancer Biomarkers

8 minute read

How to Develop Predictive Cancer Biomarkers

March 6, 2020

Cancer Cell Line Authentication

6 minute read

Cancer Cell Line Authentication

January 22, 2020

Cancer Biomarkers: Improving Detection and Treatment

8 minute read

Cancer Biomarkers: Improving Detection and Treatment

November 5, 2019

Targeting Tumor-Associated Antigens and Tumor-Specific Antigens

5 minute read

Targeting Tumor-Associated Antigens and Tumor-Specific Antigens

September 17, 2019

Circulating Tumor Cells in Preclinical Mouse Models of Metastasis

6 minute read

Circulating Tumor Cells in Preclinical Mouse Models of Metastasis

August 20, 2019

Recapitulating Clinical Metastatic Events in Preclinical Mouse Models

5 minute read

Recapitulating Clinical Metastatic Events in Preclinical Mouse Models

July 19, 2019

Targeting the FGF/FGFR Signaling Axis with PDX Models

7 minute read

Targeting the FGF/FGFR Signaling Axis with PDX Models

February 12, 2019

Where Do Organoids Fit in Preclinical Cancer Modeling?

6 minute read

Where Do Organoids Fit in Preclinical Cancer Modeling?

November 29, 2018

Immunocompetent Murine Tumor Models: Spontaneous Tumor, Dissociated Tumor Cells and Murine Tumor Fragments

7 minute read

Immunocompetent Murine Tumor Models: Spontaneous Tumor, Dissociated Tumor Cells and Murine Tumor Fragments

October 11, 2018

Facilitating Drug Discovery with 3D In Vitro Oncology Models

4 minute read

Facilitating Drug Discovery with 3D In Vitro Oncology Models

August 17, 2018

Personalized Cancer Immunotherapy

4 minute read

Personalized Cancer Immunotherapy

July 5, 2018

Genetically Engineered or Syngeneic Mouse Models?

4 minute read

Genetically Engineered or Syngeneic Mouse Models?

May 17, 2018

The Establishment and Characterization of PDX Models

4 minute read

The Establishment and Characterization of PDX Models

April 13, 2018

ICOS: Immunostimulatory or Immunosuppressive Target?

4 minute read

ICOS: Immunostimulatory or Immunosuppressive Target?

March 13, 2018

How Gut Bacteria Influence Cancer Treatment Efficacy

3 minute read

How Gut Bacteria Influence Cancer Treatment Efficacy

November 28, 2017

Post FDA Approval: CAR-T Therapy Key Facts

4 minute read

Post FDA Approval: CAR-T Therapy Key Facts

October 26, 2017

Treatment Approaches for EGFR-Mutated Lung Cancer

5 minute read

Treatment Approaches for EGFR-Mutated Lung Cancer

September 5, 2017